Literature DB >> 7122910

Possible involvement of thromboxane in bronchoconstrictive and hypertensive effects of LTC4 and LTD4 in guinea pigs.

A Ueno, K Tanaka, M Katori.   

Abstract

The actions of leukotriene (LT) C4 and D4 on the systemic arterial pressure and the insufflation pressure in guinea pigs and rabbits were examined. In guinea pigs, 0.3 - 3 nmole/kg of LTC4 and 0.1 - 1.0 nmole/kg of LTD4 administrated from left jugular vein caused dose-dependent increase of the airway resistance measured by the Konzett-Rössler method and a triphasic blood pressure response; an initial hypotension, a secondary hypertension and a third long-lasting hypotension. All of the hypertensive phase and 100 - 150% of the increase of the airway resistance by LTC4 and LTD4 were inhibited by a selective thromboxane synthetase inhibitor, OKY-1581 (10 mg/kg, i.v.) and only the hypotension was observed. Indomethacin (10 mg/kg, i.p.) also inhibited not only the airway resistance increase, but also the prolonged hypotension by LTC4 and shortened the duration of the hypotension by LTD4. It is suggested that thromboxane might be involved in bronchoconstriction and hypertensive effects by LTC4 and LTD4 and that hypotensive prostaglandin might be involved in the hypotensive phase after LTC4 and LTD4. In rabbits, the increase of the airway resistance by LTC4 and LTD4 (upto 100 nmole/kg, i.v.) was negligible and only the hypotension was observed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7122910     DOI: 10.1016/0090-6980(82)90130-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

1.  Increased secretion of glandular-kallikrein in the bronchial washings induced by intravenous injection of leukotriene C4 in guinea-pigs.

Authors:  H Y Jin; M Katori; M Majima; N Sunahara
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  The mechanism underlying maintenance of the endocochlear potential by the K+ transport system in fibrocytes of the inner ear.

Authors:  Naoko Adachi; Takamasa Yoshida; Fumiaki Nin; Genki Ogata; Soichiro Yamaguchi; Toshihiro Suzuki; Sizuo Komune; Yasuo Hisa; Hiroshi Hibino; Yoshihisa Kurachi
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

3.  SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.

Authors:  E F Smith; M J Slivjak; J W Egan; R D Eckardt; J F Newton
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

4.  Mechanism of leukotriene-induced contraction of isolated guinea pig tracheal smooth muscle.

Authors:  T Sasaki; K Takagi; T Satake; S Sugiyama; T Ozawa
Journal:  Lung       Date:  1984       Impact factor: 2.584

5.  Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat.

Authors:  J Filep; E Földes-Filep; J C Frölich
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

6.  Pharmacological modulation of endothelin-induced contraction of guinea-pig isolated airways and thromboxane release.

Authors:  J G Filep; B Battistini; P Sirois
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

Review 7.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

Review 8.  Cardiovascular effects of leukotrienes.

Authors:  J Fauler; J C Frölich
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 9.  Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.

Authors:  Esha Sehanobish; Mohammad Asad; Mali Barbi; Steven A Porcelli; Elina Jerschow
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.